210 related articles for article (PubMed ID: 30700149)
1. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.
Coquerelle S; Ghardallou M; Rais S; Taupin P; Touzot F; Boquet L; Blanche S; Benaouadi S; Brice T; Tuchmann-Durand C; Ribeil JA; Magrin E; Lissillour E; Rochaix L; Cavazzana M; Durand-Zaleski I
Hum Gene Ther; 2019 Jun; 30(6):753-761. PubMed ID: 30700149
[TBL] [Abstract][Full Text] [Related]
2. Transplantation for thalassemia major: alternative donors.
Locatelli F; Merli P; Strocchio L
Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
[TBL] [Abstract][Full Text] [Related]
3. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
Lertkovit O; Anurathapan U; Hongeng S; Thokanit NS; Pakakasama S
Int J Hematol; 2021 Apr; 113(4):556-565. PubMed ID: 33385291
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
7. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
[TBL] [Abstract][Full Text] [Related]
8. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
Hussein AA; Al-Zaben A; Ghatasheh L; Natsheh A; Hammada T; Abdel-Rahman F; Abu-Jazar H; Sharma S; Najjar R; Frangoul H
Pediatr Blood Cancer; 2013 Aug; 60(8):1345-9. PubMed ID: 23424175
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
[TBL] [Abstract][Full Text] [Related]
10. Impact of β-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with β-thalassemia major.
Hamidieh AA; Saber T; Fayyazi S; Jalali A; Behfar M; Hamdi A; Ghavamzadeh A
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1772-6. PubMed ID: 25017762
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation in Thalassemia.
Strocchio L; Locatelli F
Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734
[TBL] [Abstract][Full Text] [Related]
12. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
[TBL] [Abstract][Full Text] [Related]
14. Allogenic Hematopoietic Cell Transplantation in Thalassemia Major: A Single-center Retrospective Analysis From India.
Choudhary D; Doval D; Sharma SK; Khandelwal V; Setia R; Handoo A
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e296-e301. PubMed ID: 30933028
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
Yesilipek MA
Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
[TBL] [Abstract][Full Text] [Related]
16. Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis.
Ghavamzadeh A; Kasaeian A; Rostami T; Kiumarsi A
Biol Blood Marrow Transplant; 2019 Feb; 25(2):307-312. PubMed ID: 30266673
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
[TBL] [Abstract][Full Text] [Related]
18. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.
Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V
Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438
[TBL] [Abstract][Full Text] [Related]
19. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
20. Effect of serum panel reactive antibodies on allogeneic hematopoietic stem cell transplantation in pediatric thalassemia patients: A single-center experience.
Malbora B; Sarbay H; Dogusan Z; Atay AA
Pediatr Transplant; 2024 Feb; 28(1):e14648. PubMed ID: 38063291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
